Researchers have demonstrated that reduction of NLRP3 expression in adipose tissue prevented the obesity-induced inflammasome activation in liver and improved insulin sensitivity in obese type-2 diabetic patients [103]. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.